---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-006099"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T13:42:29.373299+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# VolitionRx submits Breakthrough Device request to FDA for Nu.Q sepsis test; H1 revenue exceeds full-year 2022

## Summary
- Submitted Breakthrough Device Designation Request to FDA for Nu.Q technology in sepsis in June 2023.
- H1 2023 total revenue $366,000, exceeding full-year 2022 revenue; Nu.Q Vet sales grew five-fold.
- Cash $19.7M at June 30, 2023, vs $10.9M at 2022 year-end; raised $17.6M net in June public offering.
- Expects $13M in milestone payments from Heska and additional non-dilutive Belgian agency funding.
- Centers of Excellence for Nu.Q NETs progressing; first clinical paper submitted for peer review.

## SEC filing metadata
- accession: 0001477932-23-006099
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793223006099/0001477932-23-006099-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793223006099/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-006099
- JSON: https://secwatch.observer/filing/0001477932-23-006099.json
- Plain text: https://secwatch.observer/filing/0001477932-23-006099.txt

## Key facts
- Earnings Releases
  VOLITIONRX LTD reported financial results for second quarter ended June 30, 2023.
  - Period: second quarter ended June 30, 2023
  - Result: reported results
  source text: VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced financial results and a business update for the second quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/93314/000147793223006099/0001477932-23-006099-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.